Global Counterfeit Drug Detection Device Market Trends, Forecast Report 2025-2037
Counterfeit Drug Detection Device Market size is set to expand by around USD 1.48 billion, achieving a CAGR of 5.4% from 2025 to 2037. By 2025, the industry for counterfeit drug detection device is anticipated to reach a valuation of USD 1.58 billion.
The global counterfeit drug detection device market is witnessing expansion due to the increasing prevalence of counterfeit drugs, which pose strong risks to consumers' health and undermine the integrity of healthcare systems around the globe. Thus, as counterfeit medication becomes increasingly sophisticated and difficult to detect, the urgency grows for effective detection solutions that can be necessary and sufficient to assure patient safety and preserve public trust in pharmaceutical products.
To meet the demand gap, companies in the market are developing advanced technologies to detect counterfeit drugs. For instance, in March of 2023, InVita Healthcare Technologies launched Pharma Defense, the first-of-its-kind to focus specifically on testing counterfeits, a drug that will help gain the upper hand in the battle against pharmacy fraud. Additionally, governments across the world are implementing strict anti-counterfeit measures and investing in advanced detection technologies to ensure public health, thus fueling counterfeit drug detection device market growth.
Counterfeit Drug Detection Device Sector: Growth Drivers and Challenges
Growth Drivers
- Rising prevalence of counterfeit drugs: The rising trend of counterfeit drugs seriously undermines the health and well-being of the public. As per the World Health Organization (WHO) report, 1 in 10 medical products in low and middle-income countries are substandard or falsified. This surging trend has led to a rising demand for the most advanced detection equipment to authenticate drugs and safeguard consumers.
- Strict government policies: Governments in most parts of the globe are promoting strict policies and measures against the issues caused by spurious drugs. In this regard, the U.S. Food and Drug Administration (FDA) has also issued the Drug Supply Chain Security Act so that pharmaceutical products are traceable and verifiable. These strict policies are compelling pharmaceutical companies and health service providers to opt for more quality-focused anti-counterfeiting solutions that ensure counterfeit drug detection device market growth.
- Technological advancements: With spectroscopy, chromatography, and artificial intelligence technologies, counterfeit drug detection is changing the landscape. Such technologies enable faster, better, and more economical detection of the drugs that have been counterfeited. Such technologies are a necessity for safety and efficacy. For example, Metrohm AG launched a new energy-dispersive X-ray fluorescence (XRF) analyzer called the '2060 XRF Process Analyzer' in April 2024 to perform rapid, non-destructive elemental analysis.
Challenges
- Lack of awareness and training: There is still a lack of awareness and training among healthcare professionals and consumers on how to identify and report counterfeit medicines. The challenge hinders the effective use of detection equipment and requires wide-reaching education programs in drug safety to combat counterfeiting.
- Techniques of counterfeiters: The techniques used in the process of fabricating counterfeit drugs are evolving day to day. As a result, it becomes difficult for regulatory bodies and manufacturers to counter these fabricated drugs with new means for detection tools. A 2023 report by the International Criminal Police Organization (INTERPOL) finds that most sophisticated counterfeiters have web pages and use social media to strategize in distributing their commodities, so identification and implementation of such counterfeit drugs becomes cumbersome.
Counterfeit Drug Detection Device Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.4% |
|
Base Year Market Size (2024) |
USD 1.51 billion |
|
Forecast Year Market Size (2037) |
USD 2.99 billion |
|
Regional Scope |
|
Counterfeit Drug Detection Device Segmentation
Modality (Portable Devices, Handheld Devices, Benchtop Devices)
Portable devices segment in the counterfeit drug detection device market is anticipated to register around 5.7% growth till 2037 due to the increasing demand for portable as well as cost-effective, user-friendly detection solutions. Another driver of portable devices is their ability to provide immediate, easy on-site detection of counterfeit medicines, hence convenient for use at all places, including pharmacies, hospitals, and border control points.
End user (Pharmaceutical Companies, Drug Testing Laboratories, Research Organizations)
Drug testing laboratories segment is set to capture over 59.8% counterfeit drug detection device market share by 2037. The adoption of counterfeit drug detection device is rising in drug testing laboratories as they ensure the safety and efficacy of drugs by means of stringent testing and analysis of drug products. It has increased the requirement for accurate and reliable testing services and advanced detection technologies. Laboratories' collaboration with regulatory agencies helps enhance the validation of the detection methods involved, which further pushes up the standard in the industry. As counterfeit drugs continue flooding into the market, labs continue to bolster their arsenal with advanced technologies. Such progress improves their operations and makes them more responsive to this growing threat.
Our in-depth analysis of the counterfeit drug detection device market includes the following segments
|
Product |
|
|
Modality |
|
|
End user |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportCounterfeit Drug Detection Device Industry - Regional Synopsis
North America Market Analysis
North America industry is anticipated to hold largest revenue share of 34.2% by 2037. Some of the primary drivers include awareness of the dangers of counterfeit drugs and improvement in healthcare infrastructure. The region has a highly regulated pharmaceutical market, offering strict policies wherein advanced technologies are used to detect counterfeit drugs. The growing demand for medicines through e-commerce and online pharmacies elevates the need for strong authentication methods of drugs.
In the U.S., government initiatives are driving the demand for counterfeit drug detection device market. The U.S. government imposed strict regulations against counterfeit drugs, which indeed influenced a massive scale in the dynamics of the market. For example, Section 27 of R.A. 3720 provides that the U.S. FDA thoroughly checks and verifies pharmaceuticals, which promotes the buying and use of detection apparatus. Aside from its influence on market growth, these regulations also help consumers avoid buying defective and harmful counterfeit products.
Canada has strict health-related regulations with rampant cases of false pharmaceutical drugs that have notably played a role in easing some drug-related safety concerns. The government has budgeted USD 150 million in fiscal year 2024 toward stricter regulation of policies related to drug safety, an effort to combat rogue medications. It detects and eliminates false drugs before they get to the last consumer; therefore, it causes demand for identification technologies.
Asia Pacific Market Statistics
Till 2037, Asia Pacific counterfeit drug detection device market is anticipated to showcase moderate growth rate, owing to increasing cases of counterfeit pharmaceuticals in the region. The recent adaptation of online e-commerce has increased the demand for portable, efficient, and convenient drug detection technologies. Authenticating medications becomes more relevant as more people buy their drugs from online pharmacies. Thus, the urgent need for effective counterfeit detection solutions in the APAC has increased.
In India, the government has already initiated measures to counter the problem of counterfeit drugs. Health infrastructure upgrade provisions made by the government in the budget of 2024-25 amount to USD 10.66 million, primarily in the form of the upgradation of hospitals and clinics. This can be accompanied by smart detection technologies to provide better safety to patients and authenticity of drugs. High e-commerce in India has propelled the demand for reliable verification methods for drugs.
In China, strict regulatory measures are considered in dealing with this emerging issue of counterfeit drugs to make a more secure pharmaceutical environment. In 2023, fake drugs in China rose by 22% compared to the previous year. Advanced detection technology is becoming widespread considering the rise in consumer preference toward e-commerce platforms. The counterfeit drug detection device market in China is anticipated to expand with widened consumer consciousness and government initiatives on detection devices for spurious drugs.
Companies Dominating the Counterfeit Drug Detection Device Landscape
- B&W Tek
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Metrohm AG
- Thermo Fisher Scientific Inc.
- Rigaku Holding Corporation
- Konica Minolta Business Solutions Europe GmbH
- Nynomic AG
- Bruker
- Eluceda Ltd
- NanoMatrix Technologies Limited
- GAO RFID Inc.
The counterfeit drug detection device market is highly competitive, with the presence of some major key players trying to vie for market share. Key players including B&W Tek, Metrohm AG, Thermo Fisher Scientific Inc., and Rigaku Corporation, are actively developing research and development to come up with innovations and technologically advanced solutions to detect counterfeit drugs.
These companies are also focusing on strategic partnerships, mergers, and acquisitions to expand their presence in the market and expand their portfolios of products. In December 2021, Thermo Fisher Scientific Inc. acquired a leading provider of portable chemical analysis solutions step in strengthening its position in the counterfeit drug detection device market. It will significantly expand the customer base and the portfolio of Thermo Fisher's product line, boosting the competition in the market.
Here are some leading companies in the counterfeit drug detection device market
In the News
- In June 2024, Rigaku Analytical Devices announced a strategic distribution partnership with Avantor, a leading provider of mission-critical products and services to the life sciences and advanced technologies sectors. This collaboration is expected to expand Rigaku’s reach in delivering advanced analytical devices to critical industries. Through Avantor's distribution network, Rigaku aims to enhance the availability of its innovative detection solutions. The partnership is poised to improve the efficiency and reliability of counterfeit drug detection globally.
- In June 2024, Konica Minolta unveiled the launch of its CM-17d and CM-16d portable, vertical spectrophotometers. These devices are designed to provide lightweight, high-precision color measurements for various industries, including pharmaceuticals. Its portability allows for easy on-site drug verification, addressing the growing demand for real-time counterfeit detection. The launch reflects Konica Minolta's commitment to advancing spectrophotometry technology.
- In December 2023, Nynomic AG acquired Art Photonics GmbH, a specialist in fiber optic products, based in Berlin, Germany. The acquisition will see Art Photonics integrated as the thirteenth pillar within Nynomic's Dynamic Group, enhancing its technological capabilities. This strategic move is expected to strengthen Nynomic’s position in the counterfeit detection market by leveraging Art Photonics’ advanced optical solutions.
Author Credits: Radhika Pawar
- Report ID: 6470
- Published Date: Jan 10, 2025
- Report Format: PDF, PPT
